Protocol summary

Study aim
Determination of the effect of COQ10 supplement on CRP inflammatory markers and oxidative stress in COPD patients
Design
Clinical trial with control group, with parallel group; Double blind, randomized
Settings and conduct
Valiasr Hospital of Birjand - South Khorasan This study is done in the valiasr hospital in Birjand, south khorasan province. 90 patients are randomly divided into 2 intervention and control groups. blood samples are taken from patients In the beginning of the study and the antioxidant serum level is measured before the treatment is started. Then the intervention is done for 6 weeks and blood samples are taken again. Antioxidant parameters will be measured by the Lab Technician. Of the birjand university of medical science. In this study the administrative steps are done by the lab technician and both the patients and the project executive will be uninformed of the groups.
Participants/Inclusion and exclusion criteria
Inclusion criteria: 1-subject is aged 18 or older 2- subject is not taking any Nutritional or medical supplements. 3- Subject provides written informed consent. Exclusion criteria: 1- Refusal to give informed consent 2- diagnosis of mellitus diabetes, PTE, CKD, CAD and bacterial pneumonia 3- taking any complementary medicines 4- diagnosis of COPD with current treatment of antioxidant medicine and supplements or any medicine that affects antioxidant storage and mitocondrial system 5- death of the subject during the test
Intervention groups
The intervention group consists of 45 patients with COPD recieving two 60mg CoQ10 pills. The control group consists of 45 patients with COPD recieving two pills containing starch..
Main outcome variables
Total anti oxidant FEV1 FEVC DPPD Hs-CRP

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20190618043934N1
Registration date: 2019-08-26, 1398/06/04
Registration timing: registered_while_recruiting

Last update: 2019-08-26, 1398/06/04
Update count: 0
Registration date
2019-08-26, 1398/06/04
Registrant information
Name
Zabihullah Mohaghegh
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 56 3232 3232
Email address
oabstudent@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2019-06-21, 1398/03/31
Expected recruitment end date
2019-09-22, 1398/06/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Study of the Effect of Coenzyme Q10 supplementation on inflammatory markers(high-sensitivity C-reactive protein, interleukin-6, and oxidative stress and increases antioxidant enzyme activity) in patients with COPD
Public title
Study of the effect of Coq10 on patients with shortness of breath
Purpose
Supportive
Inclusion/Exclusion criteria
Inclusion criteria:
At least 18 years of age, no nutritional and pharmaceutical supplementation, and informed consent.
Exclusion criteria:
diagnosis of mellitus diabetes, PTE, CKD, CAD and bacterial pneumonia or taking any complementary medicines.Also diagnosis of COPD with current treatment of antioxidant medicine and supplements or any medicine that affects antioxidant storage and mitocondrial system.
Age
From 18 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Investigator
Sample size
Target sample size: 90
More than 1 sample in each individual
Number of samples in each individual: 2
Befor and after from intervention
Randomization (investigator's opinion)
Randomized
Randomization description
Lottery method of Simple random sampling
Blinding (investigator's opinion)
Double blinded
Blinding description
Participants in the study administrative of the study
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Birjand University of Medical Sciences
Street address
Moallem BLV-ferdowsi ST
City
Birjand
Province
South Khorasan
Postal code
9717811674
Approval date
2018-10-28, 1397/08/06
Ethics committee reference number
ir.bums.REC.1397.189

Health conditions studied

1

Description of health condition studied
COPD Disease
ICD-10 code
J44.9
ICD-10 code description
Chronic obstructive pulmonary disease, unspecified

Primary outcomes

1

Description
Serum levels of antioxidants in the serum of patients
Timepoint
Before the intervention placebo and 6 weeks after starting the Coq10 capsule
Method of measurement
thiobarbituric acid method

Secondary outcomes

1

Description
Serum levels of antioxidants in the serum of patients
Timepoint
6 weeks after taking the supplement or placebo
Method of measurement
thiobarbituric acid method

Intervention groups

1

Description
Intervention group: The intervention group will receive 2 tablets of 60 mg coccitone for 6 weeks each day.
Category
Treatment - Drugs

2

Description
Control group: The control group received 2 tablets of starch containing as a placebo for 6 days .
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Valieasr hospital
Full name of responsible person
Reza yaghobi marake
Street address
Molallem BLV-Ferdowsi ST
City
Birjand
Province
South Khorasan
Postal code
9717811674
Phone
+98 56 3232 3232
Email
oabstudent@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Birjand University of Medical Sciences
Full name of responsible person
Dr. tooba kazemi
Street address
Ghaffari BLV
City
Birjand
Province
South Khorasan
Postal code
9717811674
Phone
+98 56 3238 1200
Email
oabstudent@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Birjand University of Medical Sciences
Proportion provided by this source
50
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Birjand University of Medical Sciences
Full name of responsible person
Zabihullah mohaghegh
Position
Student
Latest degree
Bachelor
Other areas of specialty/work
General Practitioner
Street address
Moallem BLV-Ferdowsi ST
City
Birjand
Province
South Khorasan
Postal code
9717811674
Phone
+98 56 3232 3232
Email
oabstudent@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Birjand University of Medical Sciences
Full name of responsible person
Dr. gholamreza mortazavimoghaddam
Position
science Committee
Latest degree
Subspecialist
Other areas of specialty/work
Internal Medicine
Street address
Ghaffari BLV
City
Birjand
Province
South Khorasan
Postal code
9717811674
Phone
+98 56 3232 3232
Email
oabstudent@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Birjand University of Medical Sciences
Full name of responsible person
Zabihullah Mohaghegh
Position
Student
Latest degree
Bachelor
Other areas of specialty/work
General Practitioner
Street address
Moallem Blvd, Ferdowsi St.
City
Birjand
Province
South Khorasan
Postal code
9717811674
Phone
+98 56 3232 3232
Fax
Email
oabstudent@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD
There is no need to publish individual patient information
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Title and more details about the data/document
The demographic data of patients in general, along with the serum levels of antioxidants and other commonly used drugs, will be reported in general.
When the data will become available and for how long
After publishing the results as thesis And articleپژ
To whom data/document is available
Medical Researchers
Under which criteria data/document could be used
No
From where data/document is obtainable
Article or Thesis
What processes are involved for a request to access data/document
Patient personal information will not be shared with anyone.
Comments
Loading...